Výsledky vyhledávání - Dickran Kazandjian

Upřesnit hledání
  1. 1
    Multiple myeloma epidemiology and survival: A unique malignancy

    Multiple myeloma epidemiology and survival: A unique malignancy Autor Dickran Kazandjian

    Vydáno 2016
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    A look backward and forward in the regulatory and treatment history of multiple myeloma: Approval of novel-novel agents, new drug development, and longer patient survival

    A look backward and forward in the regulatory and treatment history of multiple myeloma: Approval of novel-novel agents, new drug development, and longer patient survival Autor Dickran Kazandjian, Ola Landgren

    Vydáno 2016
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non–Small Cell Lung Cancer

    Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non–Small Cell Lung Cancer Autor Dickran Kazandjian, Yutao Gong, Patricia Keegan, Richard Pazdur, Gideon M. Blumenthal

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Minimal Residual Disease-Adapted Therapy in Multiple Myeloma: Current Evidence and Opinions

    Minimal Residual Disease-Adapted Therapy in Multiple Myeloma: Current Evidence and Opinions Autor Mina Meseha, James E. Hoffman, Dickran Kazandjian, Ola Landgren, Benjamin Diamond

    Vydáno 2024
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Second malignancies in multiple myeloma; emerging patterns and future directions

    Second malignancies in multiple myeloma; emerging patterns and future directions Autor Kylee Maclachlan, Benjamin Diamond, Francesco Maura, Jens Hillengaß, Ingemar Turesson, Ola Landgren, Dickran Kazandjian

    Vydáno 2020
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Benefit-Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration-Positive, Metastatic Non-Small Cell Lung Cancer

    Benefit-Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration-Positive, Metastatic Non-Small Cell Lung Cancer Autor Dickran Kazandjian, Gideon M. Blumenthal, Lola Luo, Kun He, Ingrid Fran, Steven J. Lemery, Richard Pazdur

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements

    FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements Autor Dickran Kazandjian, Gideon M. Blumenthal, Huanyu Chen, Kun He, Mona Patel, Robert Justice, Patricia Keegan, Richard Pazdur

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma

    Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma Autor Mattias Carlsten, Neha Korde, Ritesh R. Kotecha, Robert Reger, Simona Bor, Dickran Kazandjian, Ola Landgren, Richard W. Childs

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy

    FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy Autor Dickran Kazandjian, Daniel L. Suzman, Gideon M. Blumenthal, Sirisha L. Mushti, Kun He, Meredith Libeg, Patricia Keegan, Richard Pazdur

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Overall Response Rate, Progression-Free Survival, and Overall Survival With Targeted and Standard Therapies in Advanced Non–Small-Cell Lung Cancer: US Food and Drug Administration Trial-Level and Patient-Level Analyses

    Overall Response Rate, Progression-Free Survival, and Overall Survival With Targeted and Standard Therapies in Advanced Non–Small-Cell Lung Cancer: US Food and Drug Administration... Autor Gideon M. Blumenthal, Stella Karuri, Hui Zhang, Lijun Zhang, Sean Khozin, Dickran Kazandjian, Shenghui Tang, Rajeshwari Sridhara, Patricia Keegan, Richard Pazdur

    Vydáno 2015
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Benefit-Risk Summary of Nivolumab for Patients With Metastatic Squamous Cell Lung Cancer After Platinum-Based Chemotherapy

    Benefit-Risk Summary of Nivolumab for Patients With Metastatic Squamous Cell Lung Cancer After Platinum-Based Chemotherapy Autor Dickran Kazandjian, Sean Khozin, Gideon M. Blumenthal, Lijun Zhang, Shenghui Tang, Meredith Libeg, Paul G. Kluetz, Rajeshwari Sridhara, Patricia Keegan, Richard Pazdur

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non–Small Cell Lung Cancer Trials

    Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non–Small Cell Lung Cancer Trials Autor Gideon M. Blumenthal, Lijun Zhang, Hui Zhang, Dickran Kazandjian, Sean Khozin, Shenghui Tang, Kirsten B. Goldberg, Rajeshwari Sridhara, Patricia Keegan, Richard Pazdur

    Vydáno 2017
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy

    Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy Autor Caroline E. McCoach, Gideon M. Blumenthal, L. Zhang, Adrian Myers, Shenghui Tang, R. Sridhara, Patricia Keegan, Richard Pazdur, Robert C. Doebele, Dickran Kazandjian

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients

    Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients Autor Dickran Kazandjian, Elizabeth Hill, Malin Hultcrantz, Even H. Rustad, Venkata Yellapantula, Theresia Akhlaghi, Neha Korde, Sham Mailankody, Alex Dew, Elli Papaemmanuil, Irina Marić, Mary Kwok, Ola Landgren

    Vydáno 2019
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry

    The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry Autor Hemant Kulkarni, Vincent C. Marconi, Weijing He, Michael L. Landrum, Jason F. Okulicz, Judith Delmar, Dickran Kazandjian, John Castiblanco, Seema S. Ahuja, Edwina Wright, Robin A. Weiss, Robert A. Clark, Matthew J. Dolan, Sunil K. Ahuja

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis

    Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis Autor Kelly J. Norsworthy, Flora Mulkey, Emma C. Scott, Ashley F. Ward, Donna Przepiorka, Rosane Charlab, Sarah E. Dorff, Albert Deisseroth, Dickran Kazandjian, Rajeshwari Sridhara, Julia A. Beaver, Ann T. Farrell, R. Angelo de Claro, Richard Pazdur

    Vydáno 2020
    Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Noninvasive Urinary Metabolomic Profiling Identifies Diagnostic and Prognostic Markers in Lung Cancer

    Noninvasive Urinary Metabolomic Profiling Identifies Diagnostic and Prognostic Markers in Lung Cancer Autor Ewy A. Mathé, Andrew D. Patterson, Majda Haznadar, Soumen Manna, Kristopher W. Krausz, Elise D. Bowman, Peter G. Shields, Jeffrey R. Idle, Philip B. Smith, Katsuhiro Anami, Dickran Kazandjian, Emmanuel Hatzakis, Frank J. Gonzalez, Curtis C. Harris

    Vydáno 2014
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Combination of Protein Coding and Noncoding Gene Expression as a Robust Prognostic Classifier in Stage I Lung Adenocarcinoma

    Combination of Protein Coding and Noncoding Gene Expression as a Robust Prognostic Classifier in Stage I Lung Adenocarcinoma Autor Ichiro Akagi, Hirokazu Okayama, Aaron J. Schetter, Ana I. Robles, Takashi Kohno, Elise D. Bowman, Dickran Kazandjian, Judith A. Welsh, Naohide Oue, Motonobu Saito, Masao Miyashita, Eiji Uchida, Toshihiro Takizawa, Seiichi Takenoshita, Vidar Skaug, Steen Mollerup, Aage Haugen, Jun Yokota, Curtis C. Harris

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Extreme body mass index and survival in newly diagnosed multiple myeloma patients

    Extreme body mass index and survival in newly diagnosed multiple myeloma patients Autor Urvi A. Shah, Karissa Whiting, Sean M. Devlin, Rachel Ershler, Bindu Kanapuru, David Jungpa Lee, Sabrin Tahri, Thomas Gwise, Even H Rustad, Sham Mailankody, Alexander M. Lesokhin, Dickran Kazandjian, Francesco Maura, Daniel Auclair, Brenda M. Birmann, Saad Z. Usmani, Nicole Gormley, Catherine R. Marinac, Ola Landgren

    Vydáno 2023
    Získat plný text Získat plný text
    Carta
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

    Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma Autor Ola Landgren, Jonathan N. Hofmann, Charlene M. McShane, Loredana Santo, Malin Hultcrantz, Neha Korde, Sham Mailankody, Dickran Kazandjian, Murata Kazunori, Katie Thoren, Lakshmi V. Ramanathan, Ahmet Doǧan, Even H Rustad, Sydney X. Lu, Theresia Akhlaghi, Sigurður Y. Kristinsson, Magnus Björkholm, Sean M. Devlin, Mark P. Purdue, Ruth M. Pfeiffer, Ingemar Turesson

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: